TXMD
Therapeuticsmd·NASDAQ
--
--(--)
--
--(--)
7.41 / 10
Outperform
Money-flow analysis registers 7.41/10, indicating robust fund-flow characteristics. Although the overall trend is labeled negative, the high score reflects positive momentum in smaller trade sizes and a lack of large-scale outflows. This healthy liquidity supports the stock but does not yet override the neutral technical and mixed fundamental signals.
Fund Flow Rating
What is the market sentiment for TXMD?
- TXMD holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.41/10 (Outperform).
